Processing your payment...
Please do not close your browser.

Rosuvastatin Calcium Market - Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Astra Zeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals

06 Jan, 2020 | 120 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

In 2020, the global Rosuvastatin Calcium market size was US$ 502 million and it is expected to reach US$ 665.1 million by the end of 2027, with a CAGR of 4.0% during 2022-2027. 



Rosuvastatin Calcium Market Overview



Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).



It is an approved API which can be used to reduce the risk of stroke or heart attack. Rosuvastatin calcium is a hygroscopic powder suitable for the manufacturing of capsules and tablets in which the appropriate excipients need to be added. Depending on formulation, the particle size of product is designed is a way that optimal dissolution can be obtained.



Rosuvastatin calcium is a member of the drug class of statins which is used in combination diet, exercise and weight-loss in order to treat high cholesterol and conditions related to it along with preventing cardiovascular disease. It operates by slowing the production of cholesterol in the body in order to decrease the amount of cholesterol which may build up on the walls of the arteries and block the blood flow to the brain, heart and other parts of the body.






Industry Updates:




  • July 20, 2016, Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Rosuvastatin Calcium Tablets, 5 mg, 10 mg, 20 mg and 40 mg, which is a generic version of AstraZeneca's Crestor®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product. Rosuvastatin Calcium Tablets are used in combination with diet for the treatment of high triglycerides (hypertriglyceridemia) in adults.

  • July 21, 2016, Sandoz today announced the U.S. market introduction of rosuvastatin calcium tablets, a generic version of Crestor® by AstraZeneca Pharmaceuticals LP.



What are the major Applications, Types and Regions for Rosuvastatin Calcium Market?



Rosuvastatin Calcium Market is segmented based on the type, applications, companies and regions.



Market Volume (%) By Type, it is segmented into




  • Purity 98.0%

  • Purity 99.0%

  • Others



Market Volume (%) By Applications it is segmented into




  • Tablet (including dispersible tablet and general tablet)

  • Capsule

  • Other



Rosuvastatin Calcium Market Regional Analysis



Europe remains the largest consumer of Rosuvastatin calcium with a share of 34% meanwhile China is the second producer with a market share of 28%. Key players in the market are, MSN laboratories, AstraZeneca and Changzhou pharmaceutical factory with a combined market share of 55%.



All these factors greatly affect the Rosuvastatin Calcium market growth. It further aims at providing complete overview on detailed assessment of significant features of different industries including sales value, sales volume, market revenue, and demand size, sales growth, pricing analysis and changing market growth factors in regions such as Follows,




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The Rosuvastatin Calcium Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Rosuvastatin Calcium Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Rosuvastatin Calcium Market report scope?























































Report Attributes



 



Report Details



 



Forecast Period 2022 to 2027 CAGR (Value and Volume)



 



CAGR of 4.0% during the review period (2022 to 2027).



Market Volume (%) By Type(Revenue, USD Million, 2017 - 2022)




  • Purity 98.0%

  • Purity 99.0%

  • Others



Market Volume (%) By Type(Revenue, USD Million, 2017 - 2022)




  • Tablet (including dispersible tablet and general tablet)

  • Capsule

  • Others



Quantitative units



Revenue in USD million/billion and CAGR from 2022 to 2027



By Companies



AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals, LGM Pharma, Bal Pharma, Changzhou Pharmaceutical Factory, Jingxin Pharm, Zhejiang Hisun Pharmaceutical, HEC Pharm, Lunan Pharmaceutical, Nanjing Frochem Tech, Lianyungang Runzhong Pharmaceutical, Shandong Bechem Chemicals, CTX Life Sciences



 



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



 



 



 



 



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



 



Base Year



 



 



2022



 



Historical Year



 



 



2017 to 2021



 



Forecast Year



 



 



2022 to 2027



 



Customization Available



 



 



Yes, the report can be customized as per your needs




Key Highlights from this Rosuvastatin Calcium Report




  • A comprehensive backdrop analysis, which contains an assessment of the parent market

  • Essential changes in market dynamics.

  • Market segmentation up to the second or third level.

  • Historical, current, and projected size of the market from the standpoint of both value and volume.

  • Reporting and evaluation of recent industry developments.

  • Market shares and strategies of major players.

  • Emerging niche segments and regional markets.

  • An objective assessment of the trajectory of the market.

  • Recommendations to companies for strengthening their foothold in the market.



All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.



Frequently Asked Questions



What is the study period of this market?



The Rosuvastatin Calcium Market is studied from 2017 - 2027.



What is the growth rate of Rosuvastatin Calcium Market?



The Rosuvastatin Calcium Market is growing at a CAGR of 4.0% over the next 5 years.



Who are the key players in Rosuvastatin Calcium Market?



AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals, LGM Pharma, Bal Pharma, Changzhou Pharmaceutical Factory, Jingxin Pharm, Zhejiang Hisun Pharmaceutical, HEC Pharm, Lunan Pharmaceutical, Nanjing Frochem Tech, Lianyungang Runzhong Pharmaceutical, Shandong Bechem Chemicals, CTX Life Sciences



What region does this Rosuvastatin Calcium Market report covers?



North America (the United States, Canada, and Mexico)



Europe (Germany, France, UK, Russia, and Italy)



Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)



South America (Brazil, Argentina, Colombia, etc.)



The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)



What are the significant types of Rosuvastatin Calcium Market?



Purity 98.0%, Purity 99.0%, Others



What are the major end-use applications of Rosuvastatin Calcium Market?



Tablet (including dispersible tablet and general tablet), Capsule, Others.


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL ROSUVASTATIN CALCIUM MARKET BY TYPES

    3. GLOBAL ROSUVASTATIN CALCIUM MARKET BY APPLICATION



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASED DEMAND FROM APPLICATIONS

      2. INCREASING DEMAND FOR ROSUVASTATIN CALCIUM



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST OF RAW MATERIAL



    3. OPPORTUNITIES

      1. ROSUVASTATIN CALCIUM GROWTH

      2. APPLICATION OF ROSUVASTATIN CALCIUM



    4. IMPACT OF COVID 19



  5. GLOBAL ROSUVASTATIN CALCIUM MARKET, BY TYPES

    1. Introduction

    2. Purity 98.0%

    3. Purity 99.0%

    4. Others



  6. GLOBAL ROSUVASTATIN CALCIUM MARKET, BY APPLICATION

    1. Introduction

    2. Tablet (including dispersible tablet and general tablet)

    3. Capsule

    4. Others



  7. GLOBAL ROSUVASTATIN CALCIUM MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. AstraZeneca

      2. Teva Pharmaceutical Industries

      3. MSN Laboratories

      4. Cadila Pharmaceuticals

      5. LGM Pharma

      6. Bal Pharma

      7. Changzhou Pharmaceutical Factory

      8. Jingxin Pharm

      9. Zhejiang Hisun Pharmaceutical

      10. HEC Pharm

      11. Lunan Pharmaceutical

      12. Nanjing Frochem Tech

      13. Lianyungang Runzhong Pharmaceutical

      14. Shandong Bechem Chemicals

      15. CTX Life Sciences

      16. Others.





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 9
  • 3M